Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Oral Technologies
  6.  » Developing Optimised Formulations with Minimal Drug Substance
Icon of a document with a pencil

Developing Optimised Formulations with Minimal Drug Substance

Summary: Advances in in silico and experimental techniques mean that APIs and prototype formulations can be thoroughly characterised using multiple material-sparing assays, allowing the most promising formulation candidates to move on to in vivo studies.

Download Article